Autotransfusion Devices Market 2020 Share, Global Industry Analysis & Growth Forecast by 2026

The global autotransfusion devices market size is predicted to reach USD 320.5 million by 2026, exhibiting a CAGR of 3.2% during the forecast period. The shortage of allogeneic blood and surge in invasive surgeries in developed as well as developing countries will boost the autotransfusion devices market trends in the forthcoming years. According to a survey conducted by World Health Organization (WHO) in 2016, the patient group over 60 years had the highest consumption of allogeneic blood, accounting for an estimated 79.0% of the total blood transfusion that took place in the developed regions. Moreover, the increasing number of surgical procedures and surge in critical injuries are factors expected to fuel demand for autotransfusion devices in the foreseeable future.

For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/autotransfusion-devices-market-101899

Some of the Major Companies in the Autotransfusion Devices Market are:

  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic
  • Fresenius SE & Co. KGaA
  • BD (Becton, Dickinson, and Company)
  • Beijing Jingjing Medical Equipment Co., Ltd.
  • Other Prominent Players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autotransfusion-devices-market-101899

According to the report, published by Fortune Business Insights in a report, titled “Autotransfusion Devices Market Size, Share & Industry Analysis, By Product Type (Autotransfusion Systems and Consumables & Accessories) By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, and Others) By End User (Hospitals and Specialty Clinics & Others) and Regional Forecast, 2019-2026” the market size was valued at USD 249.2 million in 2018.

The report offers valuable insights into all the dominating trends of the global autotransfusion devices market size. It provides a comprehensive synopsis of all the segments and shares analytical statistics on all the regions of the market. The report is put together after a wide-ranging investigation followed by insightful exploration to aid companies, stakeholders, financers, and potential investors. The report provides a clear depiction of the market size to help our readers acknowledge all the potential threats in the market. Besides, it also covers all the latest advancements and development, product launches, acquisitions, and collaborations & partnerships that took place in recent times.

Rising Number of Surgical Procedures to Present Lucrative Opportunities for the Market

The increasing number of surgical procedures due to the utilization of intraoperative & postoperative cell salvage will bolster healthy growth of the market during the forecast period. The rising awareness regarding the complications associated with allogeneic transfusions will contribute positively to the growth of the autotransfusion devices market in the forthcoming years. The rising number of high-bleeding surgeries among patients in developed as well as developing countries will also foster the growth of the market in the forthcoming years.

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Key Industry Developments- Partnerships, Mergers and Acquisitions
    • Number of Cardiovascular Procedures for Key Countries, 2018
    • Number of Orthopedic Procedures for Key Countries, 2018
    • Number of Obstetrics & Gynecological Procedures for Key Countries, 2018

TOC Continued...

More Trending Topics from Fortune Business Insights:

Global ePharmacy Market Size to Touch US$ 177,794.9 Mn by 2026; Growth Opportunities Witnessed Around the World to Support Expansion

Wearable Medical Devices Market Worth $139,353.6 Million by 2026, at 24.7% CAGR; Superior Treatment & Diagnostic Outcomes to Spur Demand, Fortune Business Insights™